Our Culture
Our Values
Our Values
Our History
Milestones
Milestones
Management Team
Directors
Senior Management
Responsibilities
Our Commitments
Our Commitments
Employees & Diversity
Corporate Governance
Research & Development
Intellectual Property
Awards & Grants
Quality Control
Distributors
Locations
Subsidiaries
MicroPort Lifescience Shanghai
MicroPort Lifescience Beijing
MicroPort Orthopedics
MicroPort EP
- Home
- Our Company
- Management Team
- Directors
Executive Directors

Dr. Zhaohua Chang
Dr. Zhaohua Chang is the founder, Chairman and Executive Director, Chief Science Officer, of MicroPort Scientific Corporation. Dr. Zhaohua Chang has served as one of the Directors since it was founded and assumed the responsibility of Chief Executive Officer from April 2008 to July 2010. Dr. Zhaohua Chang has over 20 years' experience in the medical device industry. He is also professor of the Medical Device College at the University of Shanghai for Science and Technology and Director of Shanghai Institute for Minimally Invasive Therapy. Prior to the establishment of the Company in 1998, Dr. Zhaohua Chang studied at the Shanghai Institute of Mechanical Engineering from 1979 to 1987 and obtained his bachelor, master and doctoral degrees. In 1992, Dr. Zhaohua Change achieved his doctoral degree of Biological Science at the State University of New York, USA. Dr. Zhaohua Chang served as Director of Research and Development and Vice President of Cryomedical Sciences between 1990 and 1995. Dr. Zhaohua Chang was the Vice President of Research and Development of Endocare Inc., a NASDAQ listed medical device company based in California, U.S., from 1996 to 1997.
Dr. Zhaohua Chang is the founder, Chairman and Executive Director, Chief Science Officer, of MicroPort Scientific Corporation. Dr. Zhaohua Chang has served as one of the Directors since it was founded and assumed the responsibility of Chief Executive Officer from April 2008 to July 2010. Dr. Zhaohua Chang has over 20 years' experience in the medical device industry. He is also professor of the Medical Device College at the University of Shanghai for Science and Technology and Director of Shanghai Institute for Minimally Invasive Therapy. Prior to the establishment of the Company in 1998, Dr. Zhaohua Chang studied at the Shanghai Institute of Mechanical Engineering from 1979 to 1987 and obtained his bachelor, master and doctoral degrees. In 1992, Dr. Zhaohua Change achieved his doctoral degree of Biological Science at the State University of New York, USA. Dr. Zhaohua Chang served as Director of Research and Development and Vice President of Cryomedical Sciences between 1990 and 1995. Dr. Zhaohua Chang was the Vice President of Research and Development of Endocare Inc., a NASDAQ listed medical device company based in California, U.S., from 1996 to 1997.

Yan Zhang
Ms. Yan Zhang is an executive Director and president of our Company. Ms. Zhang has served as a Director since July 22, 2010. Ms. Zhang also served as our senior vice president of corporate affairs, general counsel, compliance officer and Board secretary prior to July 2010. Ms. Zhang has over 16 years of legal experience practicing PRC law in China. Prior to joining us in 2006, Ms. Zhang was a senior lawyer of King & Wood, a leading law firm in China. Ms. Zhang received her master's degree in law and her bachelor's degree in law from China East University of Politics and Law in 2002 and 1991 and received the EMBA degree from China Europe International Business School in 2011, respectively.
Ms. Yan Zhang is an executive Director and president of our Company. Ms. Zhang has served as a Director since July 22, 2010. Ms. Zhang also served as our senior vice president of corporate affairs, general counsel, compliance officer and Board secretary prior to July 2010. Ms. Zhang has over 16 years of legal experience practicing PRC law in China. Prior to joining us in 2006, Ms. Zhang was a senior lawyer of King & Wood, a leading law firm in China. Ms. Zhang received her master's degree in law and her bachelor's degree in law from China East University of Politics and Law in 2002 and 1991 and received the EMBA degree from China Europe International Business School in 2011, respectively.

Hongbin Sun
Mr. Hongbin Sun is an executive Director and chief financial officer of our Company. Mr. Sun has served as a Director and our chief executive officer since July 22, 2010. He was also a supervisor of MP Shanghai until July 2010. Mr. Sun has over 10 years of finance experience. Mr. Sun was the general manager of Otsuka China from 2006 to July 2010. Mr. Sun is a member of the Chinese Institute of Certified Public Accountants and is also a Chartered Financial Analyst. Mr. Sun received his bachelor's degree in economics from Shanghai Jiao Tong University in China in 1998.
Mr. Hongbin Sun is an executive Director and chief financial officer of our Company. Mr. Sun has served as a Director and our chief executive officer since July 22, 2010. He was also a supervisor of MP Shanghai until July 2010. Mr. Sun has over 10 years of finance experience. Mr. Sun was the general manager of Otsuka China from 2006 to July 2010. Mr. Sun is a member of the Chinese Institute of Certified Public Accountants and is also a Chartered Financial Analyst. Mr. Sun received his bachelor's degree in economics from Shanghai Jiao Tong University in China in 1998.

Qiyi Luo
Mr. Qiyi Luo is an executive Director and chief technology officer of our Company. Mr. Luo has served as a Director since July 22, 2010. Mr. Luo has over 19 years of experience in the medical device industry. Prior to joining us in 2003, he worked as principal research and development engineer and senior manufacturing/development engineer at Medtronic AVE in the United States. Mr. Luo received his bachelor's degree in applied science from Yunnan University of Technology in China in 1983 and his master's degree in applied science from Queen's University in Canada in 1990.
Mr. Qiyi Luo is an executive Director and chief technology officer of our Company. Mr. Luo has served as a Director since July 22, 2010. Mr. Luo has over 19 years of experience in the medical device industry. Prior to joining us in 2003, he worked as principal research and development engineer and senior manufacturing/development engineer at Medtronic AVE in the United States. Mr. Luo received his bachelor's degree in applied science from Yunnan University of Technology in China in 1983 and his master's degree in applied science from Queen's University in Canada in 1990.
Non-executive Directors
Norihiro Ashida
Mr. Norihiro Ashida is a non-executive Director of our Company. Mr. Ashida has served as a Director since November 1, 2006 and has also served as a director of MP Shanghai since March 2004. Mr. Ashida is an executive operating officer of Otsuka Holdings, and the director of its corporate development department. Mr. Ashida received his bachelor's degree in economics from the University of Tokyo in 1977.
Hiroshi Shirafuji
Mr. Hiroshi Shirafuji is a non-executive Director of our Company. Mr. Shirafuji has served as a Director since November 1, 2006 and has also served as a director of MP Shanghai since March 2004. Mr. Shirafuji is an operating officer of Otsuka Holdings and the representative director & chairman of JIMRO Co., Ltd. ("JIMRO"), a subsidiary of Otsuka Pharmaceutical. Prior to joining JIMRO in June 2003, he was an executive director responsible for pharmaceuticals marketing at Otsuka Pharmaceutical from 1997 to 1998. Mr. Shirafuji joined Otsuka Pharmaceutical in 1967. Mr. Shirafuji received his bachelor's degree in economics from Doshisha University in Kyoto in 1967.
Lei Ding
Mr. Lei Ding is a non-executive Director of our Company. Mr. Ding has served as a Director since August 26, 2011. Mr. Ding has also served as Secretary of the Party Committee and general manager of Shanghai Zhangjiang (Group) Co., Ltd., deputy Secretary of the Party Committee and executive deputy director of the management committee of Shanghai Zhangjiang Hi-Tech Park. Mr. Ding received his bachelor’s degree of science, master's degree of science from Fudan University in 1985, 1988 respectively, and his Master of Business Administration degree from CEIBS in 2005.
Independent non-executive Directors
Zezhao Hua
Mr. Zezhao Hua was appointed as our independent non-executive Director on March 9, 2010. Mr. Hua is a noted scholar in the biotechnology and medical device fields, and has been a professor, lecturer and visiting scholar at various universities in China and the United States for more than 30 years. Mr. Hua was a visiting scholar at the Massachusetts Institute of Technology from 1980 to 1983.
Jonathan H. Chou
Mr. Jonathan H. Chou was appointed as our independent non-executive Director on September 3, 2010. Mr. Chou has over 15 years of finance experience in the United States and Asia. Mr. Chou has served as senior vice president and chief financial officer of Kulicke & Soffa Industries, Inc.(K&S), a company listed on the NASDAQ Stock Market (NASDAQ: KLIC), since December 2010. Prior to joining K&S, Mr. Chou had served as chief financial officer of American Dairy Inc., a company listed on the New York Stock Exchange (NYSE: ADY), since April 2008. Mr. Chou received a bachelor of arts degree from the State University of New York at Buffalo in 1988 and a master's degree in business administration from Fuqua School of Business at Duke University in 1999.
Guoen Liu
Dr. Guoen Liu was appointed as our independent non-executive Director on September 3, 2010. Dr. Liu is a noted scholar in the fields of health and development economics, health reform and pharmaceutical economics. Dr. Liu has served as professor of economics at Guanghua School of Management of Peking University, executive director of the Guanghua School of Management Health Economics and Management Institute of Peking University, and director of the China Center for Pharmaceutical Economics and Outcomes Research of Peking University since 2006. Dr. Liu received his bachelor's degree in mathematics from Southwestern University for Nationalities in 1981, his master's degree in statistics from Southwestern University of Finance and Economics in 1985, his Ph.D. in economics from the City University of New York in 1991, and post-doctoral training in health economics from Harvard University in 1994.



